Invasive fungal disease in patients undergoing umbilical cord blood transplantation after myeloablative conditioning regimen

Autor: José Luis Piñana, Inés Gómez, Rebeca Rodríguez-Veiga, Miguel A. Sanz, Guillermo Sanz, Carlos Carretero, Aitana Balaguer, Eva Gonzalez, Manuel Guerreiro, Lorenzo Ji, Pilar Solves, Juan Montoro, Pau Montesinos, Jaime Sanz, Miguel Salavert
Rok vydání: 2019
Předmět:
Zdroj: European Journal of Haematology. 102:331-340
ISSN: 0902-4441
DOI: 10.1111/ejh.13202
Popis: OBJECTIVE Characteristics and risk factors (RFs) of invasive fungal disease (IFD) have been little studied in the setting of umbilical cord blood transplantation (UCBT). METHOD We retrospectively included 205 single-unit myeloablative UCBT recipients with a median follow-up of 64 months. RESULTS Fifty-six episodes of IFD were observed in 48 patients (23%) at a median time of 123 days after stem cell infusion. Invasive mold disease (IMD) occurred in 42 cases, 38 of them (90%) caused by invasive aspergillosis whereas invasive yeast disease (IYD) occurred in 14 cases, most of them due to candidemia (n = 12, 86%). The 5-year cumulative incidence of IFD, IMDs, and IYDs was 24% 19%, and 7%, respectively. In multivariate analysis, three RFs for IMDs were identified: age >30 years (HR 3.5, P = 0.017), acute grade II-IV graft-versus-host disease (HR 2.3, P = 0.011), and ≥1 previous transplant (HR 3.1, P = 0.012). The probability of IMDs was 2.5%, 14%, and 33% for recipients with none, 1, or 2-3 RFs, respectively (P
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje